New hope for younger AML patients: targeted chemo combo shows promise
NCT ID NCT04269213
First seen Nov 14, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tests a chemotherapy drug called CPX-351 in people under 60 who have a type of leukemia that developed from a previous blood disorder or cancer treatment. The goal is to see how well the drug can stop the cancer from growing and achieve remission. About 21 participants will receive the treatment, and researchers will track how long any remission lasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network Cancer Institute - West Penn Hospital
Pittsburgh, Pennsylvania, 15224, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
SUNY Upstate Medical Center
Syracuse, New York, 13210, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.